PUBLISHER: Howe Sound Research | PRODUCT CODE: 2171565
PUBLISHER: Howe Sound Research | PRODUCT CODE: 2171565
Metagenomic sequencing is moving from the research bench into routine clinical and public health use. This report estimates the global metagenomic sequencing market at $2,460 million in 2026, growing 18.7% a year to $5,800 million in 2031 and adding $3,340 million of new annual spending. Clinical infectious disease adds the most new revenue, $1,166 million, and rises from 24.5% to 30.5% of the market, while public health and wastewater surveillance grows fastest at 31.1% a year. Shotgun and long-read sequencing take share from 16S methods, and clinical laboratories and hospitals overtake academic institutions as the largest customers by 2031.
The past year brought Karius tests through Mayo Clinic Laboratories, Delve Bio's plasma test, Bruker's purchase of Noscendo's DISQVER platform, Oxford Nanopore's first diagnostic approval, the end of CDC's supplemental funding for national wastewater surveillance, states bringing wastewater testing in-house, new microbiome funding and the EQT offer for Qiagen. The report covers 23 chapters, 60 tables and 49 figures, with forecasts by application, technology, sample type, customer and product for 14 countries and regions, and profiles of 44 companies.
Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information.